<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03166345</url>
  </required_header>
  <id_info>
    <org_study_id>Ibnsina-Ganna-PRP</org_study_id>
    <nct_id>NCT03166345</nct_id>
  </id_info>
  <brief_title>Use of Platelet Rich Plasma (PRP) for Improving Thin Endometrium</brief_title>
  <acronym>PRPITM</acronym>
  <official_title>Use of Platelet Rich Plasma (PRP) for Improving Thin Endometrium For IVF Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ibn Sina Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ganna Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ibn Sina Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Platelets rich plasma is simple source of growth factors and cytokines that can regulate
      endometrial growth for subgroup of thin endometrium women. It is an autologous source of this
      enhancing factors; therefore, there os no risk of using it within the same participant.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 15, 2017</start_date>
  <completion_date type="Anticipated">April 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Diameter of endometrial thickness</measure>
    <time_frame>2 days</time_frame>
    <description>How the endometrium would respond after 2 days of PRP</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>4 weeks or beyond after embryo Transfer</time_frame>
    <description>Registered fetal heartbeat 4 weeks or beyond after embryo transfer.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Poor Endometrium</condition>
  <arm_group>
    <arm_group_label>PRP injection into Uterine Cavity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PRP injection into Uterine Cavity For Treatment of Thin Endometrium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CSF (colony stimulating factor)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CSF for Treatment of Thin Endometrium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Treatment of Thin Endometrium</intervention_name>
    <description>This is a trial to improve endometrial thickness by autologous injection of PRP into the Uterine Cavity compared with CSF or no treatment.</description>
    <arm_group_label>PRP injection into Uterine Cavity</arm_group_label>
    <arm_group_label>CSF (colony stimulating factor)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women with thin endometrium

        Exclusion Criteria:

          -  serum positive hepatitis B and C women
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ayman S El-Gohary, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ganna Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed Fawzy, Lab Director</last_name>
    <phone>+201011122286</phone>
    <email>Drfawzy@me.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mohamed H Zidan, IVF Lab Director</last_name>
    <phone>+20111 7681111</phone>
    <email>hady_zam@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gannah IVF unit, Gannah Hospital</name>
      <address>
        <city>Giza</city>
        <zip>12345</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Muhammad Hady, IVF Laboratory director</last_name>
      <phone>+201117681111</phone>
      <email>hady_zam@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Muhammad El Hady, IVF Laboratory director</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IbnSina IVF Center, IbnSina Hospital</name>
      <address>
        <city>Sohag</city>
        <zip>12345</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed Fawzy, Lab Director</last_name>
      <phone>+201116604600</phone>
      <email>drfawzy001@me.com</email>
    </contact>
    <contact_backup>
      <last_name>Mohamed Y. Abdel-Rahman, M.D.</last_name>
      <phone>+201142456788</phone>
      <email>dryahyaz@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Mohamed Fawzy, Lab Director</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2017</study_first_submitted>
  <study_first_submitted_qc>May 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2017</study_first_posted>
  <last_update_submitted>January 19, 2018</last_update_submitted>
  <last_update_submitted_qc>January 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ibn Sina Hospital</investigator_affiliation>
    <investigator_full_name>Muhammad Fawzy</investigator_full_name>
    <investigator_title>IVF Lab Director</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

